Total Assets: The sum of all assets on a company's balance sheet.
Akebia Therapeutics, Inc. (AKBA) had Total Assets of $376.56M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$236.20M |
|
$-5.34M |
|
$39.46M |
|
$196.73M |
|
$212.70M |
|
$23.50M |
|
$-27.22M |
|
$-3.72M |
|
$-3.72M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$-5.34M |
|
$23.50M |
|
$24.77M |
|
257.16M |
|
257.16M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$252.96M |
|
$1.22M |
|
$123.61M |
|
|
Total Assets |
$376.56M |
$162.94M |
|
$48.25M |
|
$181.02M |
|
$343.95M |
|
$32.61M |
|
$-26.43M |
|
$32.61M |
|
265.43M |
|
| Cash Flow Statement Financials | |
$67.99M |
|
$-7.93M |
|
$72.93M |
|
$53.55M |
|
$186.54M |
|
$132.99M |
|
$11.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.60 |
|
1.48 |
|
83.29% |
|
9.95% |
|
9.95% |
|
10.49% |
|
-1.58% |
|
-2.26% |
|
$67.87M |
|
-- |
|
-- |
|
-- |
|
0.63 |
|
2.53 |
|
5.02 |
|
72.68 |
|
-16.39% |
|
20.22% |
|
-1.42% |
|
-6.61% |
|
$0.12 |
|
$0.26 |
|
$0.26 |
|